# FDA recall D-1238-2020

> **Golden State Medical Supply Inc.** · Class II · drug recall initiated 2020-04-03.

## Product

Losartan Potassium Tablets, USP, 25 mg, Rx only, a) 30 ct. (NDC 60429-316-30) b) 90ct. (NDC 60429-316-90) c) 1,000 ct. (60429-316-10) bottles, GSMS Incorporated, Manufactured by Arrow Pharm (Malta) Ltd., Packaged by GSMS Incorporated, Camarillo, CA 93012, USA

## Reason for recall

CGMP Deviations: Impurity for N-nitroso-N-methyl-4-aminobutryric Acid (NBMA) detected in active ingredient (API) used to manufacture finished products.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1238-2020
- **Recalling firm:** Golden State Medical Supply Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-04-03
- **Report date:** 2020-04-22
- **Termination date:** 2020-10-08

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Camarillo, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1238-2020

## Citation

> AI Analytics. FDA recall D-1238-2020. Retrieved 2026-06-09 from https://api.ai-analytics.org/recall/D-1238-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*